Logo image of CZOO

CAZOO GROUP LTD (CZOO) Stock Fundamental Analysis

NYSE:CZOO - New York Stock Exchange, Inc. - KYG2007L1216 - Common Stock - Currency: USD

6.04  +0.01 (+0.17%)

Premarket: 5.88 -0.16 (-2.65%)

Fundamental Rating

2

Overall CZOO gets a fundamental rating of 2 out of 10. We evaluated CZOO against 120 industry peers in the Specialty Retail industry. Both the profitability and financial health of CZOO have multiple concerns. CZOO is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CZOO has reported negative net income.
CZOO had a positive operating cash flow in the past year.
In the past 5 years CZOO always reported negative net income.
In the past 5 years CZOO always reported negative operating cash flow.
CZOO Yearly Net Income VS EBIT VS OCF VS FCFCZOO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 -200M -400M -600M

1.2 Ratios

CZOO has a worse Return On Assets (-133.24%) than 97.60% of its industry peers.
Industry RankSector Rank
ROA -133.24%
ROE N/A
ROIC N/A
ROA(3y)-49.23%
ROA(5y)-33.04%
ROE(3y)-359.04%
ROE(5y)-221.21%
ROIC(3y)N/A
ROIC(5y)N/A
CZOO Yearly ROA, ROE, ROICCZOO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 -200 -400 -600 -800

1.3 Margins

The Gross Margin of CZOO (1.63%) is worse than 96.80% of its industry peers.
CZOO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 1.63%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CZOO Yearly Profit, Operating, Gross MarginsCZOO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 0 -500 -1K

More info and screens

3

2. Health

2.1 Basic Checks

CZOO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CZOO has more shares outstanding
Compared to 1 year ago, CZOO has a worse debt to assets ratio.
CZOO Yearly Shares OutstandingCZOO Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 10M 20M 30M
CZOO Yearly Total Debt VS Total AssetsCZOO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 200M 400M 600M 800M 1B

2.2 Solvency

CZOO has an Altman-Z score of -2.09. This is a bad value and indicates that CZOO is not financially healthy and even has some risk of bankruptcy.
CZOO has a Altman-Z score of -2.09. This is amonst the worse of the industry: CZOO underperforms 88.00% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.09
ROIC/WACCN/A
WACC3.66%
CZOO Yearly LT Debt VS Equity VS FCFCZOO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 0 200M -200M 400M -400M 600M -600M

2.3 Liquidity

A Current Ratio of 2.12 indicates that CZOO has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.12, CZOO belongs to the top of the industry, outperforming 81.60% of the companies in the same industry.
A Quick Ratio of 1.34 indicates that CZOO should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.34, CZOO is doing good in the industry, outperforming 80.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.12
Quick Ratio 1.34
CZOO Yearly Current Assets VS Current LiabilitesCZOO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 200M 400M 600M

More info and screens

5

3. Growth

3.1 Past

CZOO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -13.52%.
CZOO shows a strong growth in Revenue. In the last year, the Revenue has grown by 90.51%.
CZOO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 913.32% yearly.
EPS 1Y (TTM)-13.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%38.68%
Revenue 1Y (TTM)90.51%
Revenue growth 3Y913.32%
Revenue growth 5YN/A
Sales Q2Q%-70.68%

3.2 Future

The Earnings Per Share is expected to grow by 23.88% on average over the next years. This is a very strong growth
CZOO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.22% yearly.
EPS Next Y63.5%
EPS Next 2Y33.6%
EPS Next 3Y23.88%
EPS Next 5YN/A
Revenue Next Year-35.48%
Revenue Next 2Y-10.27%
Revenue Next 3Y1.22%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CZOO Yearly Revenue VS EstimatesCZOO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
CZOO Yearly EPS VS EstimatesCZOO Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 -200 -400 -600 -800

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CZOO. In the last year negative earnings were reported.
Also next year CZOO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CZOO Price Earnings VS Forward Price EarningsCZOO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CZOO Per share dataCZOO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 100 -100 200 -200 300

4.3 Compensation for Growth

A more expensive valuation may be justified as CZOO's earnings are expected to grow with 23.88% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.6%
EPS Next 3Y23.88%

More info and screens

0

5. Dividend

5.1 Amount

CZOO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CAZOO GROUP LTD

NYSE:CZOO (5/20/2024, 8:04:00 PM)

Premarket: 5.88 -0.16 (-2.65%)

6.04

+0.01 (+0.17%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)10-25 2023-10-25/amc
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap29.54M
Analysts43.33
Price Target171.67 (2742.22%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-7.22%
Min Revenue beat(2)-15.75%
Max Revenue beat(2)1.32%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-37.67%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)5.98%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.02
P/FCF N/A
P/OCF 2.62
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-23.48
EYN/A
EPS(NY)-264.98
Fwd EYN/A
FCF(TTM)-3.75
FCFYN/A
OCF(TTM)2.3
OCFY38.13%
SpS324.6
BVpS-20.28
TBVpS-24.7
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -133.24%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 1.63%
FCFM N/A
ROA(3y)-49.23%
ROA(5y)-33.04%
ROE(3y)-359.04%
ROE(5y)-221.21%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover2.36
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 9.19%
Cap/Sales 1.87%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.12
Quick Ratio 1.34
Altman-Z -2.09
F-Score3
WACC3.66%
ROIC/WACCN/A
Cap/Depr(3y)77.64%
Cap/Depr(5y)N/A
Cap/Sales(3y)7.68%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-13.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%38.68%
EPS Next Y63.5%
EPS Next 2Y33.6%
EPS Next 3Y23.88%
EPS Next 5YN/A
Revenue 1Y (TTM)90.51%
Revenue growth 3Y913.32%
Revenue growth 5YN/A
Sales Q2Q%-70.68%
Revenue Next Year-35.48%
Revenue Next 2Y-10.27%
Revenue Next 3Y1.22%
Revenue Next 5YN/A
EBIT growth 1Y-33.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year67.65%
EBIT Next 3Y26.41%
EBIT Next 5YN/A
FCF growth 1Y92.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y106.32%
OCF growth 3YN/A
OCF growth 5YN/A